Aikido Pharma Inc (DOMH) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Aikido Pharma Inc  (NASDAQ: DOMH)
    Sector • Financial    Industry • Investment Services
   Industry • Investment Services
   Sector • Financial


Aikido Pharma Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Aikido Pharma Inc's ROI in the second quarter of 2026?
Aikido Pharma Inc recorded a cumulative net loss of $-68 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -64.74%.

Within the Financial sector 810 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 67 to 3596.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 86.68 % 172.59 % 156.04 % 107.32 % 5.3 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 34 64 105 216 94
Return On Investment (TTM) -64.74 % -37.82 % -17.75 % 112.44 % -32.02 %
DOMH's Overall Ranking # 3596 # 67 # 52 # 2623 #
Seq. Investment Change TTM -12.55 % 3.91 % 15.43 % 77.99 % 27.69 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -68 -45 -20 112 -18




Return On Investment DOMH's Ranking
Within: No.
Industry # 64
Sector # 811
Overall # 3596

Return On Investment Statistics
High Average Low
537.03 %
-22.33 %
-527.38 %
(Mar 31 2017)   (Mar 31 2016)







Financial Statements
Aikido Pharma Inc's II. Quarter Investments $ 34 Millions DOMH's Balance sheet
Aikido Pharma Inc's II. Quarter Income $ -5 Millions Quarterly DOMH's Income Statement
DOMH's Income by Division See DOMH's Income by Division


DOMH Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 115 43 56 74 102
Y / Y Investment Growth 165.12 % -22.54 % -24.84 % -26.72 % 243.02 %
Net Income in Millions -20 -15 -23 -18 -7
Y / Y Net Income Growth - - - - -
Annual Return On Investment -17.82 % -33.92 % -40.9 % -24.18 % -7.06 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Investment Services Industry Roi Trends and Statistics
Financial Sector Return On Investment Statistics
Roi Trends for overall market
DOMH's Roi Ratio versus Investment Services Industry, Financial Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for DOMH's Competitors
Subscribers only: Roi for Aikido Pharma Inc's Suppliers
Subscribers only: Return On Investment for DOMH's Customers

Other Ratios
DOMH's Roa DOMH's Inventory Turnover Ratio DOMH's Growth Rates DOMH's Dividend Statistics
DOMH's Profitability Ratios DOMH's Asset Turnover Ratio DOMH's Dividend Growth
DOMH's Roe DOMH's Valuation Ratios DOMH's Financial Strength Ratios DOMH's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Financial Sector ROI


Date modified: 2026-09-05T00:04:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.